-
Peaceful Repeat Vote in Douglas Ward 3 Amid Heightened Security
-
‘They want silence’: how the film NAZA is shaking Israel
-
Belgian Ambassador Marks King’s Day in Athens Amidst Strong Bilateral Trade Ties
-
Dún Laoghaire-Rathdown €335m Budget Faces Mixed Reaction Over Housing and Cost of Living
-
Rediff.com IPO Risks: Gmail Dominance and New Business Ventures
-
BING X: 22,624.66 SNC have disappeared at BingX – how safe are tokens on BingX? Will BingX’s MiCAR licence be suspended?
-
Dubai Police Expand Luxury Patrol Fleet with 525-hp Defender
-
Iran Strikes US Sites in Kuwait Following US Airstrikes on Qeshm Island
-
ESGold Expands Montauban Gold-Silver Property to Approximately 26,787 Hectares Through Strategic Claim Staking
-
Investments & Wealth Institute Expands Advanced Education Offerings for 2027, Announces Next Experience Conference in Nashville
-
Wedgewood Weddings Acquires Swan Lake Overlook, Where Alpacas, Deer, and Mountain Views Join the Guest List
-
DSS Announces Completion of Impact Biomedical Business Combination with Zoar Limited
-
Newsmax Expands Over-the-Air Reach with HC2 Broadcasting Distribution Agreement for Newsmax2
-
Impala and Philanthropy Southwest Launch Southwest Hub, Mapping Philanthropy Across Eight States
-
HTB Activ(TM) Trial Demonstrates Significant Improvement in Cognitive Abilities
-
Nixxy Announces 1-for-20 Reverse Stock Split
-
IGC Pharma Completes Dosing in Phase 2 CALMA Trial of IGC-AD1 for Agitation in Alzheimer's Dementia
-
The IRS Watchdog Just Published Its FY 2027 Challenges List - Clear Start Tax Explains Why Agency Strain Rarely Slows Down Collection Notices
-
Who Does the Best Deep Plane Facelift in Oklahoma?
-
LHH ICEO Research Led by Harvard Business School Professor Maps Four Paths for Work Beyond the C-Suite
-
cbdMD Applauds Introduction of the Bipartisan Hemp Guardrails Act, Calling It a Win for Consumer Safety, American Jobs and Tax Revenue
-
Bell Rose Capital (OTCID:BELR) Makes Major Move Into Streaming Entertainment With Spark TV Partnership And New Billy Carson Series "The Missing Chapter"
-
Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
-
NuRAN Wireless Raises First Two Towers in Benin as 4G Rollout Beats Expectations in Cameroon and Ivory Coast
-
Rockhaven Announces Successful Completion of 2026 Klaza Bulk Sample Program
-
Silver Storm to Attend the 121 Mining Investment Conference in London, UK
-
American Resources Corporation Provides Strategic Business and Financial Reporting Update
-
Who Does the Best Deep Plane Facelift in Sarasota?
-
Jumia Reports Third Quarter 2026 Results
-
Ameriwest Advances Its Copper Focused Strategy Through Proposed Sale of Railroad Valley to Pure Energy Minerals
-
1933 Industries Completes LED Lighting Retrofit at Its 68,000 Sq. Ft. Cannabis Cultivation Facility in Las Vegas, Nevada - Ranks #3 in Cannabis Flower Sales
-
AbTherx Licenses Atlas(TM) Platform to Athenova Therapeutics for Next-Generation Targeted Alpha Radiopharmaceutical Discovery
-
DataMeds AI Subsidiary Helomics, Inc. Announces Cancer Target Discovery and Anticancer Peptides Drug Development Partnership With DiaGen AI, Inc.
-
What to Do When Two Households Become One
-
SmartBuyerAI Gives Car Buyers an Itemized Check of Dealer Offers as FTC Steps Up Price Transparency Enforcement
-
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 18
-
Fulcrum Metals PLC Announces Uranium Readings up to 0.42% U(3)O(8) at Charlot-Neely
-
Leggett Dynamics Wins 2026 Automotive News PACE Pilot Award For Smart Brushless Motor
-
Wyyerd Fiber Brings Arizona's Fastest Internet to the City of Phoenix
-
Digital Infrastructure World 2027 Announces First 85 Speakers as Registrants Represent 80GW of AI Buying Capacity
-
Bill Shelow, LIBRA Insurance Partners President and CEO, Receives NAILBA’s 2026 Douglas Mooers Award for Excellence
-
Oleria Extends Identity Governance to AI Agents, Tracing Every Agent Through the People and Credentials It Acts For
-
UCLA's Scooter Jackson named Week 11 Lott IMPACT Trophy Player of the Week
-
Paris Hilton Guides Loti as Chief Advocacy Officer to Put Digital Identity Protection in Everyone's Hands
-
Ondas and Aston Martin Aramco Formula One Team Launch Multi-Year Partnership Built for "Speed to Decision"
-
Who Does the Best Testosterone Replacement Therapy in Las Vegas?
-
CMP 2026-2027 Nonprofit Leadership Pulse Check
-
Nexteer's HMDD Wins Innovation Awards from PACE Pilot, CES and AutoTech Breakthrough
-
Coa Wealth Launches AI-Powered Software That Functions as a Private Investment Office for Individual Investors and Families
-
More Than Keyboards: Epomaker Brings Its Gaming World to G-STAR 2026
Activists on trial as France debates right to die
Twelve activists accused of helping people in France to illegally obtain a euthanasia drug went on trial in Paris on Monday, as the country debates a right-to-die bill.
The defendants, aged 74 to 89, are members of Ultime Liberte (Ultimate Freedom), an association that fights to legalise assisted dying in France.
They are accused of helping dozens of people purchase pentobarbital, a drug used for physician-assisted suicide in countries such as Belgium and Switzerland, between August 2018 and November 2020.
Many of them are retired teachers with no criminal record, now facing charges of trafficking illegal substances.
If convicted, they risk up to 10 years in prison, although any sentences are expected to be much more lenient, given mitigating factors including their age.
Bernard Senet, a doctor on trial, said he had helped people who were suffering to die in better conditions.
"I am at peace because I do not feel guilty," he said.
In France, pentobarbital is only authorised to euthanise animals, while in the United States, the drug is used to carry out executions.
Few countries regulate assisted dying, and in many it remains a crime to help someone end their life, even in cases of severe and incurable suffering.
In May, France's lower house of parliament approved a right-to-die bill on first reading, the initial step in a lengthy process that could grant patients medical assistance to end their lives in clearly defined circumstances.
- 'We are satisfied' -
Outside the Paris court, members of the association rallied in support of the defendants.
"We are satisfied that there is a trial so that we can bring (the issue) to public attention," Monique Denis, the wife of one of the defendants, told AFP.
"And perhaps public opinion will come out in favour of changing the law," the 69-year-old added.
Ultime Liberte's campaign goes beyond the demands of traditional pro-euthanasia associations, advocating the right to control the manner and timing of death, whether terminally ill or not.
"Suicide has been decriminalised since the Revolution but there are many laws that prevent the freedom to commit suicide, non-violent suicide," Claude Hury, head of Ultime Liberte, told AFP ahead of the trial.
"Our goal is not to kill people," Hury said, but to help people die with dignity.
"It is to help them continue to age while being very serene about the end, provided they have this magic pill at home so they can stop when they decide to, rather than waiting for the medical diktat."
The investigation began in 2019 following a US report on a network that shipped pentobarbital worldwide, disguised in bottles labelled "natural cosmetics".
France carried out searches across the country in 2019, finding buyers who were mostly elderly or seriously ill people, though some suicides appeared unrelated to age or illness.
The investigation found that some members of the association accompanied those wishing to die by giving them information on how to order the drug or even helping them obtain it.
By sharing the information only with those who requested it, the activists did not intend to "encourage or facilitate a decision to commit suicide" but rather to "accompany" that decision, said the investigating judge.
One member said he joined the association after a relative used the group to end their life.
"I am here to see if I can help in some way, so that when I'm 80 and ill, I won't have to do it behind closed doors," said the 61-year-old, releasing only his first name, Franck.
France's draft law would allow assisted dying only in an "advanced" stage of illness, which it defines as an irreversible and worsening health condition affecting someone's quality of life.
If approved, France would join a small group of European countries that give the right to aid in dying, including Austria, Germany, Spain and Switzerland.
The trial is set to conclude on October 9.
J.Gomez--AT